» Articles » PMID: 33996970

The Development of a Juvenile Porcine Augmented Renal Clearance Model Through Continuous Infusion of Lipopolysaccharides: An Exploratory Study

Overview
Journal Front Vet Sci
Date 2021 May 17
PMID 33996970
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Augmented renal clearance (ARC) as observed in the critically ill (pediatric) population can have a major impact on the pharmacokinetics and posology of renally excreted drugs. Although sepsis has been described as a major trigger in the development of ARC in human critically ill patients, mechanistic insights on ARC are currently lacking. An appropriate ARC animal model could contribute to reveal these underlying mechanisms. In this exploratory study, a state of ARC was induced in 8-week-old piglets. Conscious piglets were continuously infused over 36 h with lipopolysaccharides (LPS) from (O111:B4) to induce sepsis and subsequently trigger ARC. To study the dose-dependent effect of LPS on the renal function, three different doses (0.75, 2.0, 5.0 μg/kg/h) were administered (two ♂ piglets/dose, one sham piglet), in combination with fluid administration (0.9% NaCl) at 6 ml/kg/h. Single boluses of renal markers, i.e., creatinine [40 mg/kg body weight (BW)], iohexol (64.7 mg/kg BW), and para-aminohippuric acid (PAH, 10 mg/kg BW) were administered intravenously to evaluate the effect of LPS on the renal function. Clinical parameters were monitored periodically. Blood sampling was performed to determine the effect on hematology, neutrophil gelatinase-associated lipocalin, and prostaglandin E plasma levels. All piglets that were continuously infused with LPS displayed an elevated body temperature, heart rhythm, and respiratory rate ~1-3 h after start of the infusion. After infusion, considerably higher total body clearances of iohexol, creatinine, and PAH were observed, independent of the administration of LPS and/or its dose. Since also the sham piglet, receiving no LPS, demonstrated a comparable increase in renal function, the contribution of fluid administration to the development of ARC should be further evaluated.

Citing Articles

Comparative Analysis of Hepatic Gene Expression Profiles in Murine and Porcine Sepsis Models.

Halimi F, Vanderhaeghen T, Timmermans S, Croubels S, Libert C, Vandewalle J Int J Mol Sci. 2024; 25(20).

PMID: 39456859 PMC: 11507144. DOI: 10.3390/ijms252011079.


Commonly disrupted pathways in brain and kidney in a pig model of systemic endotoxemia.

Olney K, de Avila C, Todd K, Tallant L, Barnett J, Gibson K J Neuroinflammation. 2024; 21(1):9.

PMID: 38178237 PMC: 10765757. DOI: 10.1186/s12974-023-03002-6.


Augmented Renal Clearance: What Have We Known and What Will We Do?.

Luo Y, Wang Y, Ma Y, Wang P, Zhong J, Chu Y Front Pharmacol. 2021; 12:723731.

PMID: 34795579 PMC: 8593401. DOI: 10.3389/fphar.2021.723731.

References
1.
Peters S, Yancy H, Deaver C, Jones Y, Kenyon E, Chiesa O . In vivo characterization of inflammatory biomarkers in swine and the impact of flunixin meglumine administration. Vet Immunol Immunopathol. 2012; 148(3-4):236-42. DOI: 10.1016/j.vetimm.2012.05.001. View

2.
Rochwerg B, Alhazzani W, Sindi A, Heels-Ansdell D, Thabane L, Fox-Robichaud A . Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med. 2014; 161(5):347-55. DOI: 10.7326/M14-0178. View

3.
Hjortrup P, Haase N, Wetterslev M, Perner A . Clinical review: Predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care patients. Crit Care. 2013; 17(2):211. PMC: 3672520. DOI: 10.1186/cc11855. View

4.
Van Hoek I, Lefebvre H, Paepe D, Croubels S, Biourge V, Daminet S . Comparison of plasma clearance of exogenous creatinine, exo-iohexol, and endo-iohexol over a range of glomerular filtration rates expected in cats. J Feline Med Surg. 2009; 11(12):1028-30. PMC: 11318765. DOI: 10.1016/j.jfms.2009.07.005. View

5.
Fitzpatrick F, Aguirre R, PIKE J, LINCOLN F . The stability of 13,14-dihydro-15 keto-PGE2. Prostaglandins. 1980; 19(6):917-31. DOI: 10.1016/0090-6980(80)90126-4. View